BANK VONTOBEL/CALL/EDWARDS LIFESCIENCES/70/0.1/21.06.24

BANK VONTOBEL/CALL/EDWARDS LIFESCIENCES/70/0.1/21.06.24 Stock

DE000VM57339

Real-time Boerse Frankfurt Warrants 04:13:14 2024-06-03 EDT
1.57 ^EUR	+1.95%

1 month	+4.76%
3 months	-3.14%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart EDWARDS LIFESCIENCES CORPORATION

Chart BANK VONTOBEL/CALL/EDWARDS LIFESCIENCES/70/0.1/21.06.24

Latest news about EDWARDS LIFESCIENCES CORPORATION

Some of the biggest splits in Corporate America	05-23	RE
Citigroup Upgrades Edwards Lifesciences to Buy From Neutral, Adjusts Price Target to $105 From $98	05-22	MT
Edwards Lifesciences : First Quarter 2024 Fact Sheet	05-15	PU
Deutsche Bank Upgrades Edwards Lifesciences to Buy From Hold, Raises Price Target to $103 From $86	05-14	MT

More news

Quotes 5-day view

Date	Price	Change
24-06-03	1.57	+1.95%
24-05-31	1.54	-10.98%
24-05-30	1.73	+6.13%
24-05-29	1.63	+2.52%
24-05-28	1.59	-6.47%

Real-time Boerse Frankfurt Warrants

Last update June 03, 2024 at 04:13 am

More quotes

Static data

Product type	Warrants
Buy / Sell	CALL
Underlying	EDWARDS LIFESCIENCES CORPORATION
Issuer	Vontobel
WKN	VM5733
ISIN	DE000VM57339
Date issued	2023-11-30
Strike	70 $
Maturity	2024-06-21 (19 Days)
Parity	10 : 1
Emission price	0.55 €
Emission volume	N/A
Settlement	règlement en espèces
Currency	EUR

Technical Indicators

Highest since issue	2.49 €
Lowest since issue	0.55 €
Delta	0x
Omega	0.000000
Premium	0x
Gearing	8.08x
Moneyness	1.991
Difference Strike	-16.89 $
Difference Strike %	-24.13%
Spread	0.04 €
Spread %	2.48%
Intrinsic value	6.404
Present value	-4.814482

Company Profile

Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (67.9%); - hemodynamic monitoring systems (15.5%); - other (16.6%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).

Sector

More about the company